Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Mattias Sandström"'
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Background The accumulation of 177Lu-DOTATATE might be influenced by the amount of administered peptide in relation to the tumor somatostatin receptor expression. The effect of the administered peptide mass on the resulting absorbed dose in
Externí odkaz:
https://doaj.org/article/32dff74e177348c5b1c53990a7ff6b8d
Publikováno v:
EJNMMI Physics, Vol 7, Iss 1, Pp 1-15 (2020)
Abstract Purpose Fractionated peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE is increasingly applied as an effective treatment for patients with disseminated neuroendocrine tumors. In parallel to dose planning before external beam r
Externí odkaz:
https://doaj.org/article/612b8977c4e5404da7c26d744477fe5a
Autor:
Nanette Freedman, Mattias Sandström, Jonathan Kuten, Natan Shtraus, Inna Ospovat, Albert Schlocker, Einat Even-Sapir
Publikováno v:
EJNMMI Physics, Vol 7, Iss 1, Pp 1-15 (2020)
Abstract Purpose Over recent years, peptide receptor radiotherapy (PRRT) has been recognized as an effective treatment for patients with metastatic neuroendocrine tumors (NETs). Personalized dosimetry can contribute to improve the outcome of peptide
Externí odkaz:
https://doaj.org/article/cd307c1f09cd4567a520d61080c066ec
Autor:
Katarina Sjögreen Gleisner, Emiliano Spezi, Pavel Solny, Pablo Minguez Gabina, Francesco Cicone, Caroline Stokke, Carlo Chiesa, Maria Paphiti, Boudewijn Brans, Mattias Sandström, Jill Tipping, Mark Konijnenberg, Glenn Flux
Publikováno v:
EJNMMI Physics, Vol 4, Iss 1, Pp 1-20 (2017)
Abstract Background Currently, the implementation of dosimetry in molecular radiotherapy (MRT) is not well investigated, and in view of the Council Directive (2013/59/Euratom), there is a need to understand the current availability of dosimetry-based
Externí odkaz:
https://doaj.org/article/b1126e85f7f84e50b56575b84a1c3960
Autor:
Caroline Stokke, Pablo Minguez Gabiña, Pavel Solný, Francesco Cicone, Mattias Sandström, Katarina Sjögreen Gleisner, Carlo Chiesa, Emiliano Spezi, Maria Paphiti, Mark Konijnenberg, Matt Aldridge, Jill Tipping, Michael Wissmeyer, Boudewijn Brans, Klaus Bacher, Carsten Kobe, Glenn Flux
Publikováno v:
EJNMMI Physics, Vol 4, Iss 1, Pp 1-9 (2017)
Abstract Background The European directive on basic safety standards (Council directive 2013/59 Euratom) mandates dosimetry-based treatment planning for radiopharmaceutical therapies. The directive comes into operation February 2018, and the aim of a
Externí odkaz:
https://doaj.org/article/3a3a30ef581b4dc48b094991e68fbc50
Autor:
Ulrika Jahn, Ezgi Ilan, Mattias Sandström, Mark Lubberink, Ulrike Garske-Román, Anders Sundin
Publikováno v:
Cancers, Vol 13, Iss 5, p 962 (2021)
Dosimetry during peptide receptor radionuclide therapy (PRRT) has mainly focused on normal organs and less on the tumors. The absorbed dose in one target tumor per patient and several response related factors were assessed in 23 pancreatic neuroendoc
Externí odkaz:
https://doaj.org/article/fa7ea4b9b5f546c5a6d343e91103d04a
Autor:
Achyut Ram Vyakaranam, Joakim Crona, Olov Norlén, Dan Granberg, Ulrike Garske-Román, Mattias Sandström, Katarzyna Fröss-Baron, Espen Thiis-Evensen, Per Hellman, Anders Sundin
Publikováno v:
Cancers, Vol 11, Iss 7, p 909 (2019)
Peptide receptor radiotherapy (PRRT) with 177Lu-DOTATATE has emerged as a promising therapy for neuroendocrine tumors (NETs). This retrospective cohort study aimed to assess the outcome of PRRT for 22 patients with histopathologically confirmed pheoc
Externí odkaz:
https://doaj.org/article/0fd65a888f84470ca016757e6ab06ca5
Autor:
Zohreh Varasteh, Ola Aberg, Irina Velikyan, Gunnar Lindeberg, Jens Sörensen, Mats Larhed, Gunnar Antoni, Mattias Sandström, Vladimir Tolmachev, Anna Orlova
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e81932 (2013)
Expression of the gastrin-releasing peptide receptor (GRPR) in prostate cancer suggests that this receptor can be used as a potential molecular target to visualize and treat these tumors. We have previously investigated an antagonist analog of bombes
Externí odkaz:
https://doaj.org/article/1a7181aa5eba4c93a375828928bac690
Autor:
Jonathan Gear, Caroline Stokke, Christelle Terwinghe, Silvano Gnesin, Mattias Sandström, Johannes Tran-Gia, Marta Cremonesi, Francesco Cicone, Fredrik Verburg, Roland Hustinx, Luca Giovanella, Ken Herrmann, Pablo Minguez Gabiña
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 50(7), 1861-1868. Springer-Verlag
Dosimetry can be a useful tool for personalization of molecular radiotherapy (MRT) procedures, enabling the continuous development of theranostic concepts. However, the additional resource requirements are often seen as a barrier to implementation. T
Autor:
Sophia Hober, Vladimir Tolmachev, Anna Orlova, Hadis Honarvar, Mattias Sandström, Jos Buijs, Mikael Åstrand, Johan Nilvebrant, Sarah Lindbo, Javad Garousi
Analytical RP-HPLC analysis of purified DOTA-C-(HE)3-ADAPT6 ; Mass spectrum of purified DOTA-C-(HE)3-ADAPT6 ; Overlay of circular dichroism spectra from 250-195 nm for DOTA-C-(HE)3-ADAPT6 before (blue) and after (red) heating from 20-90{degree sign}C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d2c1f011fde126e002a8dad2a9a1dba
https://doi.org/10.1158/0008-5472.22406385
https://doi.org/10.1158/0008-5472.22406385